110 related articles for article (PubMed ID: 30365079)
1. MicroRNA‑301a targets WNT1 to suppress cell proliferation and migration and enhance radiosensitivity in esophageal cancer cells.
Su H; Wu Y; Fang Y; Shen L; Fei Z; Xie C; Chen M
Oncol Rep; 2019 Jan; 41(1):599-607. PubMed ID: 30365079
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-1275 induces radiosensitization in oesophageal cancer by regulating epithelial-to-mesenchymal transition via Wnt/β-catenin pathway.
Xie C; Wu Y; Fei Z; Fang Y; Xiao S; Su H
J Cell Mol Med; 2020 Jan; 24(1):747-759. PubMed ID: 31733028
[TBL] [Abstract][Full Text] [Related]
3. FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.
Su H; Jin X; Zhang X; Zhao L; Lin B; Li L; Fei Z; Shen L; Fang Y; Pan H; Xie C
J Transl Med; 2015 Mar; 13():104. PubMed ID: 25888911
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma.
Jin YY; Chen QJ; Wei Y; Wang YL; Wang ZW; Xu K; He Y; Ma HB
J Radiat Res; 2016 Sep; 57(5):468-476. PubMed ID: 27422937
[TBL] [Abstract][Full Text] [Related]
5. Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways.
Li Z; Jin H; Mao G; Wu L; Guo Q
Exp Cell Res; 2017 Dec; 361(1):170-177. PubMed ID: 29054489
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression.
Sun J; Ma Q; Shu C; Xiong J; Li B; Wu J; Zhang S; Li J; Liu J; Wang J
Int J Oncol; 2021 Jan; 58(1):45-56. PubMed ID: 33367931
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells.
Su H; Jin X; Shen L; Fang Y; Fei Z; Zhang X; Xie C; Chen X
Tumour Biol; 2016 Apr; 37(4):5355-63. PubMed ID: 26561473
[TBL] [Abstract][Full Text] [Related]
8. miRNA‑30a‑3p inhibits metastasis and enhances radiosensitivity in esophageal carcinoma by targeting insulin‑like growth factor 1 receptor.
Fan Y; Bian X; Qian P; Wen J; Yan P; Luo Y; Wu J; Zhang Q
Mol Med Rep; 2019 Jul; 20(1):81-94. PubMed ID: 31115568
[TBL] [Abstract][Full Text] [Related]
9. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
[TBL] [Abstract][Full Text] [Related]
10. MiR-139 Affects Radioresistance in Esophageal Cancer by Targeting the PDK1/AKT/Cyclin D1 Signaling Pathway.
Liu Y; Liu Y; Jiao WP
Bull Exp Biol Med; 2023 Feb; 174(4):489-496. PubMed ID: 36899199
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
[TBL] [Abstract][Full Text] [Related]
12. Effects of miR‑106b‑3p on cell proliferation and epithelial‑mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma.
Qiao G; Dai C; He Y; Shi J; Xu C
Int J Mol Med; 2019 Apr; 43(4):1817-1829. PubMed ID: 30816445
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel NRAGE involved in the radioresistance of esophageal cancer cells.
Zhou H; Zhang G; Xue X; Yang Y; Yang Y; Chang X; Ge X; Xiao Z; Guo H; Wang Y
Tumour Biol; 2016 Jul; 37(7):8741-52. PubMed ID: 26738870
[TBL] [Abstract][Full Text] [Related]
14. Identification of microRNAs involved in the radioresistance of esophageal cancer cells.
Su H; Jin X; Zhang X; Xue S; Deng X; Shen L; Fang Y; Xie C
Cell Biol Int; 2014 Mar; 38(3):318-25. PubMed ID: 24155113
[TBL] [Abstract][Full Text] [Related]
15. RFC3 induces epithelial‑mesenchymal transition in lung adenocarcinoma cells through the Wnt/β‑catenin pathway and possesses prognostic value in lung adenocarcinoma.
Gong S; Qu X; Yang S; Zhou S; Li P; Zhang Q
Int J Mol Med; 2019 Dec; 44(6):2276-2288. PubMed ID: 31661124
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway.
Jin Y; Xu K; Chen Q; Wang B; Pan J; Huang S; Wei Y; Ma H
Exp Cell Res; 2018 Jan; 362(2):362-369. PubMed ID: 29208461
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma.
Di X; He G; Chen H; Zhu C; Qin Q; Yan J; Zhang X; Sun X
J Gastroenterol Hepatol; 2019 Apr; 34(4):728-735. PubMed ID: 29968320
[TBL] [Abstract][Full Text] [Related]
18. PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.
Park M; Yoon HJ; Kang MC; Kwon J; Lee HW
Tumour Biol; 2016 Oct; 37(10):14217-14224. PubMed ID: 27557627
[TBL] [Abstract][Full Text] [Related]
19. IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma.
Zang C; Liu X; Li B; He Y; Jing S; He Y; Wu W; Zhang B; Ma S; Dai W; Li S; Peng Z
Oncotarget; 2017 Feb; 8(7):11228-11238. PubMed ID: 28061440
[TBL] [Abstract][Full Text] [Related]
20. SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma.
Qin Y; Zhang Y; Tang Q; Jin L; Chen Y
Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):138-148. PubMed ID: 28069586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
